| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.82▲ | 2.82▼ | 2.83▼ | 2.77▲ | 2.67▲ |
| MA10 | 2.83▼ | 2.83▼ | 2.81▲ | 2.76▲ | 2.83▼ |
| MA20 | 2.81▲ | 2.78▲ | 2.73▲ | 2.62▲ | 2.97▼ |
| MA50 | 2.74▲ | 2.78▲ | 2.70▲ | 2.83▼ | 3.24▼ |
| MA100 | 2.75▲ | 2.65▲ | 2.67▲ | 2.94▼ | 2.40▲ |
| MA200 | 2.69▲ | 2.82▲ | 2.88▼ | 3.19▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.000▼ | 0.008▲ | 0.039▲ | -0.020▼ |
| RSI | 55.081▲ | 56.605▲ | 57.975▲ | 52.057▲ | 45.919▼ |
| STOCH | 46.717 | 56.296 | 79.479 | 52.997 | 31.760 |
| WILL %R | -50.000 | -36.364 | -21.053▲ | -37.705 | -73.298 |
| CCI | -44.115 | 11.396 | 52.059 | 77.155 | -54.784 |
|
Friday, August 08, 2025 04:44 AM
Kiora Pharmaceuticals (NASDAQ:KPRX), a clinical-stage biotech focused on therapies for vision loss and retinal diseases, released its second-quarter results on August 8, 2025.
|
|
Tuesday, March 25, 2025 04:30 AM
KIORA PHARMACEUTICALS Hedge Fund Activity We have seen 0 institutional investors add shares of KIORA PHARMACEUTICALS stock to their portfolio, and 1 decrease their positions in their most recent ...
|
|
Saturday, December 21, 2024 04:00 PM
Find the latest analyst research, reports, and ratings for Kiora Pharmaceuticals, Inc. Common Stock (KPRX) at Nasdaq.com.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/08/25 | 2.90 | 2.90 | 2.78 | 2.78 | 20,805 |
| 27/08/25 | 2.82 | 2.88 | 2.82 | 2.86 | 48,015 |
| 26/08/25 | 2.7058 | 2.85 | 2.6899 | 2.841 | 76,438 |
| 25/08/25 | 2.6694 | 2.70 | 2.65 | 2.65 | 11,129 |
| 22/08/25 | 2.595 | 2.73 | 2.53 | 2.73 | 27,100 |
| 21/08/25 | 2.59 | 2.66 | 2.55 | 2.62 | 29,800 |
| 20/08/25 | 2.65 | 2.70 | 2.559 | 2.65 | 15,300 |
| 19/08/25 | 2.90 | 2.90 | 2.66 | 2.67 | 48,300 |
| 18/08/25 | 2.99 | 2.99 | 2.75 | 2.88 | 87,500 |
| 15/08/25 | 2.60 | 3.01 | 2.59 | 2.93 | 380,500 |
|
|
||||
|
|
||||
|
|